Expression levels of Mfn2, Fis1, Drp1, and Opa1 in sarcopenic muscle are down-regulated, suggesting a role for mitochondrial dysfunction in the pathogenesis of sarcopenia and skeletal muscle atrophy (Di Liu et al., 2021). Here, OPA1 is linked to sarcopenia.